Ainslie Whiting

784 total citations
10 papers, 324 citations indexed

About

Ainslie Whiting is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Ainslie Whiting has authored 10 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cell Biology and 4 papers in Physiology. Recurrent topics in Ainslie Whiting's work include Cellular transport and secretion (9 papers), Retinal Development and Disorders (6 papers) and Calcium signaling and nucleotide metabolism (3 papers). Ainslie Whiting is often cited by papers focused on Cellular transport and secretion (9 papers), Retinal Development and Disorders (6 papers) and Calcium signaling and nucleotide metabolism (3 papers). Ainslie Whiting collaborates with scholars based in Australia, Germany and United States. Ainslie Whiting's co-authors include Adam McCluskey, Phillip J. Robinson, Ngoc Chau, Mohammed K. Abdel‐Hamid, Lisa von Kleist, Volker Haucke, Mark J. Robertson, James Daniel, Anna Mariana and Luke R. Odell and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Organic & Biomolecular Chemistry.

In The Last Decade

Ainslie Whiting

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ainslie Whiting Australia	8	203	157	52	36	31	10	324
Yi Cui China	10	191 0.9×	106 0.7×	41 0.8×	62 1.7×	24 0.8×	14	340
Yuanyuan Hua China	12	209 1.0×	144 0.9×	83 1.6×	37 1.0×	30 1.0×	22	469
Izabella Niewczas United Kingdom	10	244 1.2×	157 1.0×	41 0.8×	50 1.4×	26 0.8×	17	432
Young Ah Kim United States	8	283 1.4×	60 0.4×	22 0.4×	68 1.9×	37 1.2×	14	419
Sulochanadevi Baskaran United States	11	292 1.4×	256 1.6×	58 1.1×	106 2.9×	94 3.0×	12	664
Mostafa Zarei Germany	15	409 2.0×	92 0.6×	25 0.5×	52 1.4×	10 0.3×	21	517
Nancy E. Go Canada	15	591 2.9×	74 0.5×	37 0.7×	40 1.1×	37 1.2×	20	737
Roeland Vanhoutte Belgium	8	235 1.2×	51 0.3×	42 0.8×	49 1.4×	20 0.6×	12	367
Mohammed K. Abdel‐Hamid Egypt	12	225 1.1×	73 0.5×	191 3.7×	20 0.6×	12 0.4×	14	402
Aljona Gutschmidt Germany	8	286 1.4×	187 1.2×	34 0.7×	51 1.4×	4 0.1×	8	472

Countries citing papers authored by Ainslie Whiting

Since Specialization

Citations

This map shows the geographic impact of Ainslie Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ainslie Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ainslie Whiting more than expected).

Fields of papers citing papers by Ainslie Whiting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ainslie Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ainslie Whiting. The network helps show where Ainslie Whiting may publish in the future.

Co-authorship network of co-authors of Ainslie Whiting

This figure shows the co-authorship network connecting the top 25 collaborators of Ainslie Whiting. A scholar is included among the top collaborators of Ainslie Whiting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ainslie Whiting. Ainslie Whiting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Odell, Luke R., Nigel C. Jones, Ngoc Chau, et al.. (2023). The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models. RSC Medicinal Chemistry. 14(8). 1492–1511. 3 indexed citations

Robertson, Mark J., Lisa von Kleist, Jennifer R. Baker, et al.. (2016). 5-Aryl-2-(naphtha-1-yl)sulfonamido-thiazol-4(5H)-ones as clathrin inhibitors. Organic & Biomolecular Chemistry. 14(47). 11266–11278. 10 indexed citations

Daniel, James, Ngoc Chau, Mohammed K. Abdel‐Hamid, et al.. (2015). Phenothiazine‐Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin‐Mediated Endocytosis. Traffic. 16(6). 635–654. 118 indexed citations

Abdel‐Hamid, Mohammed K., Kylie A. MacGregor, Luke R. Odell, et al.. (2015). 1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity. Organic & Biomolecular Chemistry. 13(29). 8016–8028. 19 indexed citations

MacGregor, Kylie A., Mohammed K. Abdel‐Hamid, Luke R. Odell, et al.. (2014). Development of quinone analogues as dynamin GTPase inhibitors. European Journal of Medicinal Chemistry. 85. 191–206. 25 indexed citations

MacGregor, Kylie A., Mark J. Robertson, Kelly A. Young, et al.. (2013). Development of 1,8-Naphthalimides as Clathrin Inhibitors. Journal of Medicinal Chemistry. 57(1). 131–143. 25 indexed citations

Robertson, Mark J., Ainslie Whiting, Anna Mariana, et al.. (2012). The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity. ACS Medicinal Chemistry Letters. 3(5). 352–356. 35 indexed citations

Gordon, Christopher P., Mark J. Robertson, Kelly A. Young, et al.. (2012). Development of Second-Generation Indole-Based Dynamin GTPase Inhibitors. Journal of Medicinal Chemistry. 56(1). 46–59. 39 indexed citations

Wang, Xiaohong, Ki H. Kim, Ayesha B. Alvero, et al.. (2011). Triphendiol (NV-196), development of a novel therapy for pancreatic cancer. Anti-Cancer Drugs. 22(8). 719–731. 7 indexed citations

10.

Odell, Luke R., Christopher P. Gordon, Mark J. Robertson, et al.. (2010). The Pthaladyns: GTP Competitive Inhibitors of Dynamin I and II GTPase Derived from Virtual Screening. Journal of Medicinal Chemistry. 53(14). 5267–5280. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact